A case of atezolizumab-associated tubulointerstitial nephritis

Patients with bladder cancer commonly present with post-renal acute kidney injury (AKI). Here we describe a rare case of AKI, developed within 15 months of the anti-programmed death-ligand 1 antibody therapy in a patient with bladder cancer and normally functioning suprapubic urinary catheter.